Login to Your Account



Other News To Note


Thursday, April 19, 2012

• RegeneRx Biopharmaceuticals Inc., of Rockville, Md., said scientists at the Gladstone Institute of Cardiovascular Disease at the University of California, San Francisco, published animal data in Nature showing that the process of converting nonbeating heart muscle cells into functional beating-heart muscle cells can be enhanced using Thymosin beta 4 (Tbeta4).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription